# US 2019/0376882 A1 · Composition and Method for Disrupting Tissue Material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376882 A1
- Document ID: US20190376882A1
- Status: Published application
- Kind: A1
- Application number: 15/576,871
- Filed: 2016-05-27
- Published: 2019-12-12
- Earliest claimed: 2015-05-27
- Applicants: QIAGEN GmbH
- Inventors: Dominic O'NEIL; Tanya SPERLING; Stefanie SCHROEER
- Web page: https://patentgrep.com/patent/US20190376882A1

## CPC

- C12N 1/06: Lysis of microorganisms
- G01N 1/4044: {by chemical techniques; Digestion; Chemical decomposition}
- C12N 1/066: by physical processes
- G01N 1/286: {involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising (microtomes G01N1/06; pulverising in general B02C; mixing in general B01F)}
- C12N 2509/00: Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N 2509/10: Mechanical dissociation
- G01N 2001/2866: {Grinding or homogeneising}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a composition for disrupting tissue material, the composition comprising solid disrupting particles in combination with at least one enzyme for enzymatic lysis and at least one chaotropic agent , as well as to a method for disrupting tissues material by simultaneously applying mechanical grinding or milling disruption and enzymatic digestion.

## Claims

### Claim 1

A composition for disrupting solid tissue material, comprising
one or more solid disrupting particles;
at least one enzyme for enzymatic lysis;
at least one chaotropic agent in a total concentration equal to or less than 1M;
and which does not comprise an alcohol in an amount, which denatures or inactivates the at least one enzyme.

### Claim 2 (depends on 1)

The composition according to claim 1, further comprising one or more agents selected from
at least one surfactant;
at least one nuclease inhibitor;
at least one anti-foaming agent;
at least one osmotic stabilizer:
at least one reducing agent;
and mixtures thereof.

### Claim 3 (depends on 1)

The composition according to claim 1, further comprising at least one additional enzyme, other than the enzyme for enzymatic lysis.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the at least one enzyme for enzymatic lysis is a protease.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein the tissue material is selected from human and animal derived solid tissue.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein the at least one chaotropic agent is guanidinium hydrochloride.

### Claim 7 (depends on 1)

The composition according to claim 1, wherein the solid disrupting particles exhibit a size of at least 1 mm.

### Claim 8 (depends on 7)

The composition according to claim 7, wherein the solid disrupting particles exhibit a size of >2 mm.

### Claim 9 (depends on 7)

The composition according to claim 7, wherein the solid disrupting, particles exhibit a size of ≥3 mm.

### Claim 10

A kit for disrupting tissue material, the kit comprising
one or more solid disrupting particles;
at least one enzyme for enzymatic lysis;
at least one buffer;
at least one chaotropic agent in a total concentration equal to or less than 1 M;
and optionally one or more agents selected from
at least one surfactant;
at least one nuclease inhibitor;
at least one anti-foaming agent;
at least one osmotic stabilizer;
at least one reducing agent;
at least one additional enzyme, other than the enzyme for enzymatic lysis;
at least one organic solvent; and
optionally a container for receiving the tissue material;
and a leaflet with instructions for processing the tissue material.

### Claim 11 (depends on 1)

A system comprising the composition as defined in claim 1 and a device for effecting milling of the tissue material.

### Claim 12 (depends on 11)

The system according to claim 11, further comprising a tissue material for disruption.

### Claim 13

A method for disrupting tissue material, wherein the tissue material is subjected to a simultaneous treatment of
mechanical disruption by grinding, milling or beating and
chemical disruption by enzymatic lysis,
by grinding, milling or beating the tissue material in a lysis solution which comprises one or more solid disrupting particles, at least one enzyme for enzymatic lysis, and at least one chaotropic agent in a total concentration equal to or less than 1M and which does not comprise an alcohol in an amount, which denatures or inactivates the at least one enzyme.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the at least one chaotropic agent is guanidinium hydrochloride.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the disruption is carried out by using a low-power mixer.

### Claim 16

(canceled)

### Claim 17 (depends on 13)

The method according to claim 13, comprising the steps:
(i) adding to a tissue material in a suitable container
the one or more solid disrupting particles, the at least one buffer, the at least one enzyme for enzymatic lysis, the at least one chaotropic agent, optionally an RNase, and optionally one or more agents selected from surfactants, osmotic stabilizers, reducing agents, nuclease inhibitors, anti-foaming agents or mixtures thereof;
(ii) optionally closing the container;
(iii) disrupting the tissue material in the container using a high-power mixing mill, a high-speed mixer, or a low-power mixer;
(iv) incubating the mixture of step (iii) at elevated temperature;
(v) optionally repeating step (iii) and (iv);
(vi) optionally providing the resulting mixture for subsequent purification, separation, extraction and/or analytic process steps.

### Claim 18 (depends on 1)

The composition according to claim 1, further comprising at least one buffer.

### Claim 19 (depends on 2)

The composition according to claim 2, wherein the at least one surfactant is a non-ionic surfactant.

### Claim 20 (depends on 3)

The composition according to claim 3, wherein the at least one additional enzyme is an RNase,

### Claim 21 (depends on 4)

The composition according to claim 4, wherein the protease is proteinaseK.

### Claim 22 (depends on 10)

The kit according to claim 10, wherein the at least one additional enzyme is an RNase.

### Claim 23 (depends on 10)

The kit according to claim 10, wherein the at least one organic solvent is an alcohol.

### Claim 24 (depends on 11)

The system according to claim 11, wherein the device is a high-power mixing mill, a high-speed mixer, or a low-power mixer.

### Claim 25 (depends on 11)

The system according to claim 11, wherein the device is a vortexer.

### Claim 26 (depends on 10)

A system comprising the kit as defined in claim 10 and a device for effecting milling of the tissue material.

### Claim 27 (depends on 26)

The system according to claim 26, further comprising a tissue material for disruption.

### Claim 28 (depends on 26)

The system according to claim 26, wherein the device is a high-power mixing mill, a high-speed mixer, or a low-power mixer.

### Claim 29 (depends on 26)

The system according to claim 26, wherein the device is a vortexer.

### Claim 30 (depends on 15)

The method according to claim 15, wherein the low-power mixer is a vortexer.

### Claim 31 (depends on 17)

The method according to claim 17, wherein the low-power mixer is a vortexer.
